NUCATS is a member of the National Clinical and Translational Science Award (CTSA) Consortium. The CTSA program is part of the National Center for Advancing Translational Sciences (NCATS) Division of Clinical Innovation at National Institutes of Health (NIH), which plans, conducts and supports research across the clinical phases of the translational science spectrum.
NUCATS is a founding member of the Regional Chicago CTSA Consortium (RC3).
NUCATS is part of the NCATS-supported administrative supplement grant, "Enhancing Clinical Research Professionals' Training and Qualifications" (UL1TR000433-08S1). The nine-month project, awarded to NUCATS in September 2014, involves working with the University of Michigan and other CTSA members to achieve two aims: (1) develop and implement standardized Good Clinical Practice training and (2) develop and implement a competency-based education curriculum for study teams across the CTSA consortium that equips a highly-qualified workforce with the necessary competencies to effectively, efficiently, and safely execute clinical trials. Read about the first national GCP meeting hosted by NUCATS>
Northwestern University is an inaugural member of the Strategic Pharma Academic Research Consortium (SPARC) for Translational Medicine. Members of SPARC include four institutions supported by the National Institutes of Health Clinical and Translational Science Awards: Indiana Clinical and Translational Sciences Institute (CTSI), which includes Indiana University, Purdue University and the University of Notre Dame, and institutions at Northwestern University, Ohio State University and Washington University in St. Louis. The consortium's industry partners are Eli Lilly and Co. and Takeda Pharmaceuticals International Inc. Read more about this partnership>
When using NUCATS services, it is required to cite the CTSA grant number in your publication.